uniQure Announces Presentations at Upcoming March Conferences
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, March 01, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced presentations at the following conferences taking place in March:
37 th Annual Cowen & Co. Healthcare Conference, at the Boston Marriott Copley Place, in Boston Massachusetts.
-
Matthew Kapusta, chief executive officer, will present on Wednesday, March 8 th at 10.00 a.m. EST. The live webcast can be accessed through the link displayed in the Investor section of the uniQure website at: http://uniqure.com/investors-newsroom/events-presentations.php . The webcast replay will be available for at least two weeks following the live event.
Oppenheimer 27th Annual Healthcare Conference, at the Westin New York Grand Central, in New York City.
-
Matthew Kapusta, chief executive officer, will participate in a Fireside Chat with analyst Hartaj Singh on Tuesday March 21 st at 3.55 p.m. EST. The live webcast can be accessed through the link displayed in the Investor section of the uniQure website at: http://uniqure.com/investors-newsroom/events-presentations.php . The webcast replay will be available for at least two weeks following the live event.
11th Annual Symposium of the Coalition for Hemophilia B, at the Sawgrass Marriott Golf Resort in Ponte Vedra, Florida.
-
uniQure will be exhibiting throughout the conference from Friday March 31st to Sunday April 2nd.
About uniQure
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with hemophilia, Huntington's disease and cardiovascular diseases.
www.uniQure.com
uniQure Contacts: Maria E. Cantor Direct: 339-970-7536 Mobile: 617-680-9452 m.cantor@uniQure.com Tom Malone Direct: 339-970-7558 Mobile: 339-223-8541 t.malone@uniQure.com Eva M. Mulder Direct: +31 20 240 6103 Mobile: +31 6 52 33 15 79 e.mulder@uniQure.com
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: uniQure N.V. via GlobeNewswire
Upcoming Life Sciences Events
- April 2024
- Pharma-Biotech Product & Company Valuation - An Introductory
- Basel: Swiss Biotech Day 2024
- London: BioTrinity 2024